Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany

Femme et Homme Max 99 ans
Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany MAJ Il y a 4 ans

A Phase II/III, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of atacicept in combination with corticosteroids and sequential therapy with cyclophosphamide and azathioprine in subjects with lupus nephritis PRIMARY The primary objective of this trial is to evaluate the efficacy of atacicept compared to placebo in subjects with active LN who are receiving corticosteroids and sequential therapy with cyclop...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations